Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tack

Showing results (521-530 of 727) with videos related to

Pageof 73
Sort By:
Clinical Immunology (Orlando, Fla.)|June 16, 2015
One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitusEdwin J P van Asseldonk, Pleun C M van Poppel, Dov B Ballak, et al.
Diabetes Care|February 3, 2011
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trialTim Heise, Cees J Tack, Robert Cuddihy, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2007
New algorithm for the treatment of gastro-oesophageal reflux diseaseG N Tytgat, K McColl, J Tack, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 5, 2002
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patientsE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
British Journal of Clinical Pharmacology|October 9, 2015
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinomaAnna Maria J Thijs, Cees J Tack, Winette T A van der Graaf, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2007
Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux diseaseJ M Conchillo, M P Schwartz, M Selimah, et al.
Clinical Science (London, England : 1979)|March 1, 2002
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetesE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study GroupJ M Gwaltney, S Savolainen, P Rivas, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.
Pageof 73

Showing results (521-530 of 727) with videos related to

Sort By:
Pageof 73
Clinical Immunology (Orlando, Fla.)|June 16, 2015
One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitusEdwin J P van Asseldonk, Pleun C M van Poppel, Dov B Ballak, et al.
Diabetes Care|February 3, 2011
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trialTim Heise, Cees J Tack, Robert Cuddihy, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2007
New algorithm for the treatment of gastro-oesophageal reflux diseaseG N Tytgat, K McColl, J Tack, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 5, 2002
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patientsE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
British Journal of Clinical Pharmacology|October 9, 2015
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinomaAnna Maria J Thijs, Cees J Tack, Winette T A van der Graaf, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2007
Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux diseaseJ M Conchillo, M P Schwartz, M Selimah, et al.
Clinical Science (London, England : 1979)|March 1, 2002
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetesE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study GroupJ M Gwaltney, S Savolainen, P Rivas, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.
Pageof 73